Cleared Traditional

K022096 - URIC ACID ASSAY FOR THE ADVIA INTEGRATE...

K022096 is the FDA 510(k) clearance for URIC ACID ASSAY FOR THE ADVIA INTEGRATE... by Bayer Diagnostics Corp.. It is a Class 1 Chemistry device (product code KNK) cleared through the Traditional 510(k) pathway after a 264-day FDA review.

K022096 · Bayer Diagnostics Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2003
Decision
264d
Days
Class 1
Risk

K022096 is an FDA 510(k) clearance for the URIC ACID ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM. Classified as Acid, Uric, Uricase (colorimetric) (product code KNK), Class I - General Controls.

Submitted by Bayer Diagnostics Corp. (Tarrytown, US). The FDA issued a Cleared decision on March 18, 2003 after a review of 264 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1775 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Bayer Diagnostics Corp. devices

Submission Details

510(k) Number K022096 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 27, 2002
Decision Date March 18, 2003
Days to Decision 264 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
176d slower than avg
Panel avg: 88d · This submission: 264d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code KNK Acid, Uric, Uricase (colorimetric)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1775
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - KNK Acid, Uric, Uricase (colorimetric)

All 79
Devices cleared under the same product code (KNK) and FDA review panel - the closest regulatory comparables to K022096.
OLYMPUS URIC ACID REAGENT, MODEL OSR6X98
K062862 · Olympus America, Inc. · Apr 2007
VITALAB URIC ACID REAGENT
K040467 · Clinical Data, Inc. · Mar 2004
ATAC PAK URIC ACID REAGENT AND ATAC CALIBRATOR
K031044 · Clinical Data, Inc. · Jul 2003
WAKO L-TYPE UA F TEST
K993469 · Wako Chemicals USA, Inc. · Nov 1999
SYNCHRON CX SYSTEMS URIC ACID (URIC) REAGENT
K970919 · Beckman Instruments, Inc. · May 1997
URIC ACID (LIQUID) REAGENT SET
K970560 · Pointe Scientific, Inc., · Mar 1997